期刊文献+

慢性乙型肝炎患者血清HBV DNA定量检测与抗原抗体模式的关系 被引量:2

Relationship between the serum HBV DNA content detection and antigen-antibody mode in patients with chronic type B hepatitis
下载PDF
导出
摘要 目的探讨慢性乙型肝炎患者血清HBV DNA含量与抗原抗体模式的关系,为慢性乙型肝炎的诊治及预防提供科学依据。方法采用荧光标记定量聚合酶链反应和酶联免疫吸附实验法检测180例慢性乙型肝炎患者血清HBV DNA含量和抗原抗体,统计分析不同抗原抗体模式HBV DNA含量。结果在HBsAg和HBeAg同时阳性模式中,HBV DNA含量>103copy.ml-1者114例(91.20)%,其中>107copy.ml-1者44例(35.20%);在HBsAg和抗-HBe同时阳性模式中,HBV DNA含量>103copy.ml-1者18例(56.25%),其中>107copy.ml-1者4例(12.50%)。HBeAg阳性模式HBV DNA含量显著高于HBeAg阴性模式(Ρ<0.01)。结论HBeAg阳性模式HBV DNA含量高于HBeAg阴性模式,HBeAg阳性模式中少数人HBV DNA含量很低,HBeAg阴性模式中少数人HBV DNA含量很高。仅根据抗原抗体模式,难以准确地判断病毒复制程度及传染性的强弱。 Objective To explore relationship between the serum HBV DNA content and antigen - antibody mode in patients with chronic hepatitis B(CHB). Methods Fluorescence quantitative polymerase chain reaction (PCR) was used to detect the HBV DNA content and enzyme linked immunosorbent assay ( ELISA )was used to detect the antigen- antibody in 180 CHB patients. Results HBV DNA content were more than 10^3 copy·ml^-1, and 10^7 copy·ml^-1 (were 90.6 % and 34.6 % respectively)among the HBsAg and HBeAg positive patients. HBV DNA content were less than 10^3 copy/ml ( 35.5% ), more than 10^7 copy/ml (12.9%) among the HBsAg and anti- HBe positive patients. The HBV DNA content in HBeAg positive patients were significantly higher than that in HBeAg negative patients (P 〈 0.05). Conclusion The HBV DNA content in HBeAg positive patients are significantly higher than that in HBeAg negative patients, ,some HBeAg positive patients' HBV DNA content are very low, and some HBeAg negative patients' HBV DNA content are very high. it is difficult to judge accu rately the degrees of viral replication and infectivity according to the antigen - antibody mode.
出处 《新乡医学院学报》 CAS 2006年第3期297-298,共2页 Journal of Xinxiang Medical University
关键词 慢性乙型肝炎 乙型肝炎病毒核酸 定量聚合酶链反应 定量检测 chronic hepatitis B HBV DNA quantitative polymerase chain reaction
  • 相关文献

参考文献6

二级参考文献17

  • 1田琦琦,贾克明.乙型肝炎病毒基因前C区变异的动态观察[J].中华内科杂志,1995,34(4):232-234. 被引量:28
  • 2张复春,吴婉芬,董惠卿,蔡晓莉,魏绍静,冼超.定量聚合酶链反应检测血清中HBV DNA及其临床应用[J].中华传染病杂志,1997,15(1):24-27. 被引量:130
  • 3Chen C H,J Virol Methods,1995年,53卷,131页
  • 4Kwoks, Higuchi R. Avoiding fales positives with PCR Nature, 1989, 339: 237-238.
  • 5Gayno S. Detection of HBV DNA in serum of chronic B hepatitis before actwalenes using PCR. Hepatology, 1992, 14: 357.
  • 6Loeb KR, Jerome KR, Goddard J, et al. High-throughout quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology, 2000, 32: 626-629.
  • 7Weinberger KM, Wiedenmann E, Bohm S, et al. Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR). J Virol Methods, 2000, 85: 75-82.
  • 8Pas SD, Fries E, DeMan RA, et al. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol, 2000, 38: 2897-2901.
  • 9Hunt CM, Mcgill JM, Allen MI, et al. Clinical relevance of hepatitis B viral mutations. Hepatology, 2000, 31: 1037-1044.
  • 10Mason AL, Xu L, Guo L, et al. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology, 1998, 27: 1736-1742.

共引文献14476

同被引文献28

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部